Emjard M 5 mg+500 mg (Tablet)

Unit Price: ৳ 15.00 (3 x 10: ৳ 450.00)
Strip Price: ৳ 150.00

Medicine Details

Indications

  • Adjunct treatment for type 2 diabetes mellitus in adults
  • Combined use with Metformin or other diabetes medications
  • Treatment for patients already using Empagliflozin and Metformin separately

Pharmacology

  • Inhibitor of Sodium-Glucose Co-Transporter 2 (SGLT2)
  • Reduces renal reabsorption of glucose
  • Decreases hepatic glucose production
  • Improves insulin sensitivity
  • Increases urinary glucose excretion

Dosage & Administration

  • Dosage individualized based on effectiveness and tolerability
  • Take twice daily with meals
  • Gradual dose escalation for reduced gastrointestinal side effects

Interaction

  • Increased urine volume with diuretics
  • Risk for hypoglycemia with insulin or insulin secretagogues
  • Monitoring glycemic control with urine glucose tests not recommended

Contraindications

  • Hypersensitivity to Empagliflozin and Metformin
  • Acute metabolic acidosis
  • Severe renal failure
  • Conditions altering renal function
  • Tissue hypoxia
  • Hepatic impairment
  • Acute alcohol intoxication

Side Effects

  • Urinary tract infection
  • Female genital mycotic infections
  • Diarrhea
  • Nausea/vomiting
  • Flatulence
  • Abdominal discomfort
  • Hypoglycemia
  • Increased urination
  • Thirst
  • Rash
  • Taste disturbance
  • Headache

Pregnancy & Lactation

Not recommended during pregnancy and breastfeeding

Precautions & Warnings

  • Lactic Acidosis
  • Hypotension
  • Ketoacidosis
  • Acute kidney injury
  • Increased risk for urinary tract infections
  • Hypoglycemia risk
  • Vitamin B12 Deficiency
  • Increased LDL-C
  • No established evidence for macrovascular risk reduction

Overdose Effects

  • No toxicity observed with single doses of Empagliflozin up to 800 mg
  • No hypoglycemia observed with Metformin doses up to 85 g
  • Lactic acidosis is a medical emergency and must be treated in hospital
  • Haemodialysis is the most effective method to remove lactate and Metformin

Therapeutic Class

Combination Oral hypoglycemic preparations

Storage Conditions

Keep below 30°C, protected from light & moisture, out of reach of children

Related Brands